|
Q1 FY2027
As of Sep 26, 2026
|
Q4 FY2026
As of Jun 27, 2026
|
Q3 FY2026
As of Mar 28, 2026
|
Q2 FY2026
As of Dec 27, 2025
|
Q1 FY2026
As of Sep 27, 2025
|
Q4 FY2025
As of Jun 28, 2025
|
Q3 FY2025
As of Mar 29, 2025
|
Q2 FY2025
As of Dec 28, 2024
|
Q1 FY2025
As of Sep 28, 2024
|
Q4 FY2024
As of Jun 29, 2024
|
Q3 FY2024
As of Mar 30, 2024
|
Q2 FY2024
As of Dec 30, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jul 1, 2023
|
Q3 FY2023
As of Apr 1, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Oct 1, 2022
|
Q4 FY2022
As of Jul 2, 2022
|
Q3 FY2022
As of Apr 2, 2022
|
Q2 FY2022
As of Jan 1, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade receivables, net of credit losses of $3,924 and $4,659 | ||||||||||||||||||||
| Contract assets, net of credit losses of $1,196 and $856 | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Deferred income tax asset | ||||||||||||||||||||
| Other long-term assets: | ||||||||||||||||||||
| Deferred income tax asset | ||||||||||||||||||||
| Other, net of credit losses of $8,446 and $8,438 | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation and vacation | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Term loans | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Deferred income tax liability | ||||||||||||||||||||
| Other long-term obligations | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common stock, no par value—shares authorized $25,000; issued and outstanding $11,066 and $10,859 shares, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...